Alan Kluger

Psychology City University of New York, New York, NY, United States 
Cognitive Psychology
"Alan Kluger"
Mean distance: 35622
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Guerrero-Berroa E, Kluger A, Schmeidler J, et al. (2014) Neuropsychological and neuropsychiatric prediction of global cognitive status among older Spanish-speaking Hispanics and English-speaking whites. Journal of Geriatric Psychiatry and Neurology. 27: 266-75
Yau PL, Kluger A, Borod JC, et al. (2014) Neural substrates of verbal memory impairments in adults with type 2 diabetes mellitus. Journal of Clinical and Experimental Neuropsychology. 36: 74-87
Reisberg B, Jamil IA, Khan S, et al. (2010) Staging Dementia Principles and Practice of Geriatric Psychiatry: Third Edition. 162-169
Myers CE, Kluger A, Golomb J, et al. (2008) Learning and generalization tasks predict short-term cognitive outcome in nondemented elderly. Journal of Geriatric Psychiatry and Neurology. 21: 93-103
Reisberg B, Ferris SH, Kluger A, et al. (2008) Mild cognitive impairment (MCI): a historical perspective. International Psychogeriatrics / Ipa. 20: 18-31
Sailor K, Antoine M, Diaz M, et al. (2004) The Effects of Alzheimer's Disease on Item Output in Verbal Fluency Tasks Neuropsychology. 18: 306-314
Myers CE, Shohamy D, Gluck MA, et al. (2003) Dissociating hippocampal versus basal ganglia contributions to learning and transfer. Journal of Cognitive Neuroscience. 15: 185-93
Myers CE, Kluger A, Golomb J, et al. (2002) Hippocampal atrophy disrupts transfer generalization in nondemented elderly. Journal of Geriatric Psychiatry and Neurology. 15: 82-90
Reisberg B, Ferris SH, Franssen EH, et al. (1996) Mortality and temporal course of probable Alzheimer's disease: a 5-year prospective study. International Psychogeriatrics / Ipa. 8: 291-311
Reisberg B, Franssen EH, Bobinski M, et al. (1996) Overview of methodologic issues for pharmacologic trials in mild, moderate, and severe Alzheimer's disease. International Psychogeriatrics / Ipa. 8: 159-93
See more...